SCHEMBL5068765

SCHEMBL5068765

C=CC(=O)Oc1ccc(OC(=O)C=Cc2ccccc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.71
SMN1; SMN2 Q16637 2/20 0.52
LMNA P02545 3/20 0.50
MAPT P10636 3/20 0.50
MAOB P27338 2/20 0.50
ALDH1A1 P00352 2/20 0.50
MAOA P21397 1/20 0.50
HDAC3 O15379 1/20 0.50
TNKS O95271 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HCAR2 Q8TDS4 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
TNKS2 Q9H2K2 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5068764 1.00 KMT2A (0.71) KMT2ASMN1; SMN2LMNAMAPTMAOB
SCHEMBL16982630 0.91 KMT2A (0.83) KMT2ASMN1; SMN2LMNAMAPTMAOB
SCHEMBL13904877 0.91 KMT2A (0.63) KMT2ASMN1; SMN2MAPTMAOBMAOA
SCHEMBL14275343 0.91 KMT2A (0.63) KMT2ASMN1; SMN2MAPTMAOBMAOA
SCHEMBL8836075 0.89 KMT2A (0.60) KMT2ASMN1; SMN2LMNAMAPTHDAC1
SCHEMBL544695 0.89 KMT2A (0.60) KMT2ASMN1; SMN2LMNAMAPTHDAC1
SCHEMBL8756092 0.88 KMT2A (0.73) KMT2ASMN1; SMN2LMNAMAPTMAOB
SCHEMBL8756097 0.88 KMT2A (0.73) KMT2ASMN1; SMN2LMNAMAPTMAOB
SCHEMBL4822165 0.87 KMT2A (0.68) KMT2ASMN1; SMN2LMNAMAPTMAOB
SCHEMBL4822161 0.87 KMT2A (0.68) KMT2ASMN1; SMN2LMNAMAPTMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080049319-A1 POLYMERIZABLE MONOMER, AN OPTICAL COMPENSATION FILM AND A METHOD FOR PRODUCING THE OPTICAL COMPENSATION FILM FUJIFILM CORPORATION (JP) 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080049319-A1 POLYMERIZABLE MONOMER, AN OPTICAL COMPENSATION FILM AND A METHOD FOR PRODUCING THE OPTICAL COMPENSATION FILM NR2E3, RAD51, RXFP3 KMT2A 2350/4885SMN1; SMN2 858/4885LMNA 2627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.